Heritability of Opioid Effects: A Twin Study

NACompletedINTERVENTIONAL
Enrollment

242

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Pain
Interventions
DRUG

Alfentanil

Target controlled intravenous infusion of alfentanil at a plasma concentration of 100ng/ml

OTHER

Saline placebo infusion

Intravenous infusion of normal saline

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

SRI International

INDUSTRY

lead

Martin Angst

OTHER

NCT00672438 - Heritability of Opioid Effects: A Twin Study | Biotech Hunter | Biotech Hunter